AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28860012
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of rocuronium (bolus-NMB-group)
Trial: 18705632
Drug: Metronidazole 0.75%
RxNorm normalized name: METRONIDAZOLE 0.75% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 0.75% cream
Trial: 31168802
Drug: Subcutaneous crenezumab
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous crenezumab (300mg) every 2 weeks
Trial: 24002929
Drug: Landiolol hydrochloride
RxNorm normalized name: Landiolol Hydrochloride
DrugBank: Landiolol (DB12212)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Landiolol hydrochloride (low dose): 0.125 mg/kg/min (1 min) loading followed by 0.02 mg/kg/min (20 min) continuous infusion
Trial: 22842835
Drug: Progressive resistance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive resistance training (PRT) for three months, twice a week, focusing on lower limb muscles
Trial: 20542898
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 mg, 2-4 hours prior to surgery)
Trial: 20542898
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (400 mg, 6-8 hours prior to surgery)
Trial: 17269558
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil concentrate (6 g/d, 4.4 g of LCn‐3PUFA)
Trial: 17302060
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ineffective treatment)
Trial: 15818102
Drug: Omeprazole suspension
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole suspension
Trial: 24473536
Drug: Testosterone therapy
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone therapy (150-μg testosterone patch)
Trial: 31033909
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri DSM 17938 (L. reuteri)
Trial: 27684290
Drug: Aripiprazole treatment
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole treatment
Trial: 2576363
Drug: terfenadine 60
RxNorm normalized name: terfenadine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine 60 mg
Trial: 10877493
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (5,000 IU retinyl palmitate and 30 mg beta-carotene daily, plus 200,000 IU retinyl palmitate at delivery)
Trial: 14686231
Drug: Intravenous ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir
Trial: 16769180
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg oral THC (30 mg three times a day)
Trial: 22483675
Drug: Dose-limiting constraints
RxNorm normalized name: Constrained Metal (Curcuma Longa)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-limiting constraints
Trial: 30585832
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid prophylaxis (80 mg daily for 14 days)
Trial: 11032056
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment
Trial: 31085338
Drug: Standard cut-off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cut-off value for abnormal FIT result (20 or more μg hemoglobin/g feces)
Trial: 31085338
Drug: Lower cut-off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower cut-off value for abnormal FIT result (10 or more μg hemoglobin/g feces)
Trial: 26491284
Drug: Pulmonary rehabilitation
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary rehabilitation with 18 µg of tiotropium once daily
Trial: 22470429
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/d
Trial: 10647072
Drug: Caffeine ingestion
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine ingestion (5 mg/kg fat-free mass)
Trial: 8137114
Drug: mianserin (antidepressant)
DrugBank: Mianserin (DB06148)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mianserin (antidepressant)
Trial: 2512256
Drug: Immediate ibuprofen
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Immediate ibuprofen (2400 mg/day)
Trial: 1861487
Drug: Phase I
RxNorm normalized name: Nuvelle TS Phase I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase I exercise therapy
Trial: 28724636
Drug: Ranibizumab therapy
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab therapy
Trial: 17879083
Drug: Sclerosing polidocanol
RxNorm normalized name: Polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sclerosing polidocanol injections (Group A)
Trial: 24283110
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg (n=94)
Trial: 29236049
Drug: Vitamin D₃
RxNorm normalized name: vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D₃ 200,000 IU followed by monthly 100,000 IU doses (n = 226)
Trial: 26003640
Drug: Imipenem administered
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem administered every 6 hours
Trial: 21594660
Drug: Inpatient pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient pain therapy for 3 weeks
Trial: 2515822
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy
Trial: 3553496
Drug: All drug
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drug groups
Trial: 30799269
Drug: LIA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LIA with LB 266 mg/20 mL admixed with bupivacaine HCl 0.5% 20 mL
Trial: 10622383
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate infusion therapy (40 mg/kg, maximum 2 g)
Trial: 26687471
Drug: L-PRF+ group
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-PRF+ group (n = 17)
Trial: 10664331
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation with oral antibiotics (group 2)
Trial: 8858230
Drug: Oral insertion
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral insertion of thin video endoscope
Trial: 1623912
Drug: Magnesium hydroxide
RxNorm normalized name: Magnesium Hydroxide
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium hydroxide (850 mg) with tolbutamide (500 mg)
Trial: 26528636
Drug: Median values
RxNorm normalized name: diphenhydramine hydrochloride Oral Capsule [Valu-Dryl]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Median values of galectin‐3 (13.4ng/mL)
Trial: 2007319
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg anhydrous theophylline administered as a two-stage infusion during 24 hours
Trial: 3716914
Drug: Caffeine administration
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine administration
Trial: 2141247
Drug: Plasma-derived vaccine
RxNorm normalized name: Haptoglobulin 1/1 (Plasma Derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma-derived vaccine (Heptavax-B)
Trial: 15505596
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (1200 mg/d)
Trial: 15606398
Drug: Mesalazine micropellets
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalazine micropellets (3 g/day)
Trial: 11599659
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 150 IU/kg s.c. three times weekly (t.i.w.)
Trial: 20187135
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (M/EM group)
Trial: 1871540
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg intravenous injection every 12 hours until the 3rd postoperative day
Trial: 9715861
Drug: Cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol 100 mg PO BID for 12 weeks
Trial: 9933701
Drug: UFT 300
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT 300 mg/day (P0 group)
Trial: 20017916
Drug: High-energy drink
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-energy drink (Meltdown RTD); 140 ml administered in two 70 ml doses, separated by 30 min.
Trial: 15492476
Drug: Continuous dosing
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous dosing of nitrates (n=86)
Trial: 12135034
Drug: 51 g
RxNorm normalized name: DIMETHYL SULFONE 0.51 g in 0.51 g ORAL TABLET [MSM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 51 g polyethylene glycol (PEG) laxative
Trial: 12135034
Drug: 85 g
RxNorm normalized name: UREA 17 g in 85 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 85 g polyethylene glycol (PEG) laxative
Trial: 29275880
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Rosuvastatin + Cand+HCTZ)
Trial: 24389433
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m² and carboplatin (AUC 6 mg/min/ml) without panitumumab
Trial: 16551919
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic wound infiltration with 0.25% bupivacaine 20 mL
Trial: 9331228
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg oral alprazolam
Trial: 11092290
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (HOE 901)
Trial: 9314855
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) administration (150 micrograms intra-arterial bolus, with or without a 10 mg GTN patch for 24 hours)
Trial: 23608249
Drug: Lowest vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowest vitamin D quartile (1-15.9 ng/ml)
Trial: 8590530
Drug: Fibrate therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrate therapy
Trial: 28940451
Drug: Vilaprisan 2
RxNorm normalized name: Vilaprisan
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan 2 mg/day
Trial: 7162387
Drug: Pangamic acid
RxNorm normalized name: pangamic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pangamic acid (6 tablets of 50 mg per day)
Trial: 27579992
Drug: Telephone-delivered problem-solving
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-delivered problem-solving treatment (PST)
Trial: 25050589
Drug: Submicron diclofenac
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Submicron diclofenac 35 mg tid
Trial: 12564664
Drug: Otic drops
RxNorm normalized name: Otic Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otic drops (Dex‐Otic)
Trial: 28103950
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (no tube)
Trial: 24074360
Drug: DHA 250
RxNorm normalized name: DHA 250 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA 250 mg/day
Trial: 17845540
Drug: IFN 3
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN 3 MU daily plus ribavirin (RBV) 1000 mg/day for 4 weeks, followed by IFN 3 MU TIW plus RBV 1000 mg/day for 44 weeks (induction)
Trial: 17845540
Drug: IFN 5
RxNorm normalized name: cpm/PE/DM/acetaminophen/guaifn 5 mg-10 mg-325 mg-200 mg (day)/2 mg-5 mg-10 mg-325 mg(night) ORAL TABLET, SEQUENTIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN 5 MU B.I.D. plus RBV 1000-1200 mg/day for 2 weeks, followed by pegylated IFN (PEG-IFN) 75-150 mug weekly plus RBV 1000-1200 mg/day for 46 weeks (induction)
Trial: 17845540
Drug: PEG-IFN 75-150
RxNorm normalized name: PEG-IFN alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEG-IFN 75-150 mug weekly plus RBV 1000-1200 mg/day for 48 weeks (non-induction)
Trial: 17850734
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus pioglitazone
Trial: 3545941
Drug: Bacampicillin 400
RxNorm normalized name: bacampicillin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin 400 mg twice daily
Trial: 3545941
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times daily dosages of bacampicillin, ampicillin, amoxycillin
Trial: 1495197
Drug: Cefdinir 3
RxNorm normalized name: cefdinir 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefdinir 3 mg/kg administered 30 minutes after meal
Trial: 1495197
Drug: Cefdinir mean
RxNorm normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefdinir mean dose of 4.8 mg/kg t.i.d. for 8 days
Trial: 25193003
Drug: Treatment (TX)
RxNorm normalized name: Hongo Killer Treatment
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (TX)
Trial: 22932256
Drug: Menopausal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Menopausal hormone therapy (MHT)
Trial: 9932568
Drug: Intracervical dinoprostone
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracervical dinoprostone gel
Trial: 14659852
Drug: Beta-radiation therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-radiation therapy (188Re-MAG3)
Trial: 19222614
Drug: Dopamine agonist
RxNorm normalized name: Dopamine agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine agonist (DA)
Trial: 15559871
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg daily
Trial: 6143666
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatments
Trial: 21539525
Drug: High Drug
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Drug Burden Index (DBI ≥1) after adjustment
Trial: 8842510
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (transdermal nicotine patches)
Trial: 31115592
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (5 mg intravenous infusion) + calcium + calcitriol
Trial: 18955426
Drug: Structured educational
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured educational programme of daily incremental physical activity at home (walking and skeletal muscle resistance training, with booklets and written instructions)
Trial: 31980143
Drug: Adjuvant capecitabine
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjuvant capecitabine for six months at the usual dose
Trial: 16043733
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg twice a day
Trial: 19493418
Drug: Group S1
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group S1 (propofol target plasma concentration of 4.0 microg/ml)
Trial: 19493418
Drug: Group S2
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group S2 (initial target plasma concentration of 2.0 microg/ml raised to 4.0 microg/ml after 3 minutes)
Trial: 23506344
Drug: Compression therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression therapy alone (Control)
Trial: 2920535
Drug: 94 mg
RxNorm normalized name: ivacaftor 94 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 94 mg of iron per day as ferrous sulphate with multivitamins
Trial: 2007318
Drug: Oral furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral furosemide
Trial: 15087628
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg ropivacaine
Trial: 29149865
Drug: Cytoreductive surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoreductive surgery (CRS) + hyperthermic intra‐operative peritoneal chemotherapy (HIPC) with cisplatin
Trial: 8528638
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with IL‐2 and LAK cells
Trial: 11171650
Drug: Selective attenuation
RxNorm normalized name: varicella, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective attenuation of GH‐releasing hormone feedforward signal intensity
Trial: 28069654
Drug: Therapeutic drug
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic drug monitoring (TDM)
Trial: 11139109
Drug: High-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose aprotinin (2 x 10^6 KIU pre-CPB, 2 x 10^6 KIU in prime, 500,000 KIU/hr during CPB)
Trial: 2692407
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (0.5 mg/kg in 1 liter of saline)
Trial: 15146342
Drug: low-dose haloperidol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: low-dose haloperidol
Trial: 8260856
Drug: Hydroxyzine pamoate
RxNorm normalized name: Hydroxyzine Pamoate
DrugBank: Hydroxyzine (DB00557)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxyzine pamoate (10(‐5) M in 2 ml)
Trial: 7294038
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate plus amikacin sulfate therapy
Trial: 28853202
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 20 mg/kg/d
Trial: 17681259
Drug: Biofield treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofield treatments delivered from a short distance for a total of 30 minutes before and after exposure to hydrogen peroxide.
Trial: 16244030
Drug: Small-volume fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-volume fluid management (8 mL.kg(‐1).h(‐1))
Trial: 30329136
Drug: Individualized monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Individualized monthly coaching by a physical therapist to adhere to 30 minutes of daily physical activity and 45 minutes of weekly exercise over 18 months
Trial: 11739447
Drug: CCK-8 infusion
RxNorm normalized name: CCK-8
DrugBank: Sincalide (DB09142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CCK-8 infusion